SCHEMBL18484867

SCHEMBL18484867

COC(=O)N1CC(I)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18498089 0.80 CHRNB2 (0.72) —
SCHEMBL20245183 0.80 CHRNB2 (0.42) —
SCHEMBL18231641 0.79 CHRNB2 (0.48) —
SCHEMBL12683426 0.78 CHRNB2 (0.57) —
SCHEMBL16472382 0.78 CHRNB2 (0.57) —
SCHEMBL10005081 0.78 — —
SCHEMBL14752967 0.78 — —
SCHEMBL18697087 0.77 EPHX1 (0.44) —
SCHEMBL1747846 0.76 — —
SCHEMBL7954919 0.76 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025137329-A1 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS NEUPHARMA, INC (US) 2025-06-26 — — WO disclosed
US-20220402950-A1 SUBSTITUTED BENZIMIDAZOLES AS PAD4 INHIBITORS BRISTOL-MYERS SQUIBB COMPANY 2022-12-22 — — US disclosed
WO-2017022861-A1 SUBSTITUTED GUANIDINE DERIVATIVE 宇部興産株式会社 2017-02-09 — — WO disclosed
Send feedback